Midazolam protects B35 neuroblastoma cells through Aktphosphorylation in reactive oxygen species derived cellular injury

다국어 초록 (Multilingual Abstract)

Background: Soman, a potent irreversible acetylcholinesterase (AChE) inhibitor, induces delayed neuronal injury by reactive oxygen species (ROS). Midazolam is used in patients with pathologic effects of oxidative stresses such as infection, hemodynamic instability and hypoxia. We investigated whether midazolam protects the Central Nervous System (CNS) from soman intoxication. The present study was performed to determine whether midazolam protects B35 cells from ROS stress for the purpose of exploring an application of midazolam to soman intoxication.
Methods: Glucose oxidase (GOX) induced ROS stress was used in a B35 neuroblastoma cell model of ROS induced neuronal injury. To investigate the effect of midazolam on cell viability, LDH assays and fluorescence activated cell sorting (FACS) analysis was performed. Western blotting was used for evaluating whether Akt-phosphorylation is involved in cell-protective effects of midazolam.
Results: GOX derived ROS injury decreased cell viability about 1.6-2 times compared to control; midazolam treatment (5 and 10 μg/ml) dose-dependently increased cell viability during ROS injury. On western blots, Aktphosphorylation was induced during pretreatment with midazolam; it was diminished during co-treatment with LY-294002, an inhibitor of Akt-phosphorylation. FACS analysis confirmed that the cell protective effect of midazolam is mediated by an anti-apoptotic effect. GOX-induced apoptosis was inhibited by midazolam and the finding was diminished by LY-294002.
Conclusions: Midazolam protects neuronal cells from GOX-induced ROS injury; this effect is mediated by an antiapoptotic effect through Akt-phosphorylation. This shows that midazolam may be useful in soman intoxication.

참고문헌 (Reference)

• 1 Vanhaesebroeck B, "The PI3K-PDK1 connection: more than just a road to PKB" 346 : 561-576, 2000
• 2 Nizamutdinova IT, "Tanshinone I effectively induces apoptosis in estrogen receptorpositive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells" 33 : 485-491, 2008
• 3 Matés JM, "Role of reactive oxygen species in apoptosis: implications for cancer therapy" 32 : 157-170, 2000
• 4 Simon HU, "Role of reactive oxygen species (ROS) in apoptosis induction" 5 : 415-418, 2000
• 5 McDonough JH Jr, "Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment" 16 : 123-132, 1995
• 6 Weinbroum AA, "Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison" 23 : 1258-1263, 1997
• 7 Hudson RJ, "Midazolam pharmacokinetics in patients undergoing abdominal aortic surgery" 79 : 219-225, 1994
• 8 Stevens MF, "Midazolam activates the intrinsic pathway of apoptosis independent of benzodiazepine and death receptor signaling" 36 : 343-349, 2011
• 9 Wilms H, "Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro" 14 : 417-424, 2003
• 10 Jacobsson SO, "Increased levels of nitrogen oxides and lipid peroxidation in the rat brain after soman-induced seizures" 73 : 269-273, 1999
• 11 Kang MY, "In vitro study on antioxidant potential of various drugs used in the perioperative period" 42 : 4-12, 1998
• 12 Ki Churl CHANG, "Glucose Oxidase/glucose Induces Apoptosis in C6 Glial Cells via Mitochondria-dependent Pathway" 한국응용약물학회 13 (13): 207-213, 2005
• 13 Goode HF, "Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction" 23 : 646-651, 1995
• 14 Pazdernik TL, "Chemical inducedseizures: free radicals as a final common pathway" 1 : 413-422, 1996
• 15 Prindull G, "Apoptosis in the embryo and tumorigenesis" 31A : 116-123, 1995
• 16 D'Agnillo F, "A role for the myoglobin redox cycle in the induction of endothelial cell apoptosis" 33 : 1153-1164, 2002